CDH2 and lip and oral cavity carcinoma: Taken together, these results suggest that SH003 inhibits cell migration and modulates key markers of EMT, such as E-cadherin and N-cadherin, in the YD-8, YD-9, and YD-38 oral cancer cell lines.